Lv2
190 积分 2023-04-08 加入
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
3天前
已完结
PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery
2个月前
已完结
PROTAC 2.0: Expanding the frontiers of targeted protein degradation
2个月前
已完结
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
7个月前
已完结
TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells
9个月前
已完结
A bibliometric analysis of PROTAC from 2001 to 2021
9个月前
已完结
PROTAC targeted protein degraders: the past is prologue
9个月前
已完结
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
11个月前
已完结
皖公网安备34019202002308
